PropertyValue
?:abstract
  • Access to rapid and accurate detection of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA is essential for controlling the current global pandemic of Coronavirus Disease 2019 (COVID-19). In this study, the use of oral rinses and posterior oropharyngeal saliva as an alternative to swab collection methods from symptomatic and asymptomatic healthcare workers for the detection of SARS-CoV-2 RNA by RT-PCR was evaluated. For saliva samples, the overall agreement with oropharyngeal swabs (OPS) was 93% (Ƙ=0.84) with a sensitivity of 96.7% (95%CI:83.3-99.8%). The agreement between saliva and nasopharyngeal swabs was 97.7% (Ƙ=0.93) with a sensitivity of 94.1% (95% CI:73.0-99.7%). Oral rinses were compared with NPS only, with an overall agreement of 85.7% (Ƙ=0.65), and a sensitivity of 63% (95% CI:46.6-77.8%). The agreement between a laboratory-developed test based on the CDC RT-PCR and two commercial assays, the Xpert Xpress SARS-CoV-2 and the Cobas SARS-CoV-2 was also evaluated. The overall agreement was higher than 90%. Finally, SARS-CoV-2 RNA in saliva samples was shown to be stable, with no changes in viral loads over 24 hours at both room temperature and 4ºC. While the dilution of SARS-CoV-2 in oral rinses precluded its acceptability as a sample type, posterior oropharyngeal saliva was an acceptable alternative sample type for SARS-CoV-2 RNA detection.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.jmoldx.2020.10.018
?:doi
?:journal
  • J_Mol_Diagn
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/e1e09d27da3a3e81925e2f2da7988a1a921c0586.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7670901.xml.json
?:pmcid
?:pmid
?:pmid
  • 33217552.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Performance of SARS-CoV-2 Real-time RT-PCR Tests on Oral Rinses and Saliva Samples
?:type
?:year
  • 2020-11-17

Metadata

Anon_0  
expand all